GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors

Stopped early · Early Phase 1

Conditions studied: Genitourinary Abnormality, Breast Cancer Female, Vaginal Abnormality, Urinary Tract Infections, Dyspareunia, Dysuria

In brief

The impact of treatment for GSM on the quality of life will be examined for postmenopausal women (defined as last menstrual period \> 1 year ago or 6 months ago with FSH \>40) who have been diagnosed with breast cancer.

Key facts

Study ID
NCT03185169
Run by
Alta Bates Summit Medical Center
People needed
14
Starts
2016-11-18
Expected to finish
2018-07-23
Last updated by the study team
2018-07-26

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.